Welcome to LookChem.com Sign In|Join Free

CAS

  • or

176240-12-3

Post Buying Request

176240-12-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

176240-12-3 Usage

Description

(S)-1-Benzyl-pyrrolidine-2-carbaldehyde is a chemical compound with the molecular formula C13H15NO. It is a pyrrolidine derivative featuring a benzyl group attached to the nitrogen atom. (S)-1-Benzyl-pyrrolidine-2-carbaldehyde is recognized for its unique structure and reactivity, which makes it a valuable asset in the fields of medicinal chemistry and pharmaceutical research. Its applications are primarily centered around its use as a chiral building block for the synthesis of various pharmaceuticals and biologically active molecules.

Uses

Used in Pharmaceutical Synthesis:
(S)-1-Benzyl-pyrrolidine-2-carbaldehyde is used as a chiral building block for the creation of various pharmaceuticals. Its unique structure allows for the development of new drugs with potential applications in treating a wide range of medical conditions.
Used in Organic Synthesis:
In the realm of organic synthesis, (S)-1-Benzyl-pyrrolidine-2-carbaldehyde serves as a key intermediate. Its reactivity and structural properties make it an essential component in the synthesis of potential drug candidates and bioactive compounds.
Used in Medicinal Chemistry:
(S)-1-Benzyl-pyrrolidine-2-carbaldehyde is also utilized in medicinal chemistry, where it contributes to the advancement of new drug development. Its role in this field is significant, as it aids in the design and synthesis of novel therapeutic agents.
Used in Pharmaceutical Research:
Lastly, (S)-1-Benzyl-pyrrolidine-2-carbaldehyde holds potential applications in pharmaceutical research. Its unique attributes make it a promising candidate for further exploration and development of functional materials and drug candidates that could address current and future healthcare needs.

Check Digit Verification of cas no

The CAS Registry Mumber 176240-12-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,6,2,4 and 0 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 176240-12:
(8*1)+(7*7)+(6*6)+(5*2)+(4*4)+(3*0)+(2*1)+(1*2)=123
123 % 10 = 3
So 176240-12-3 is a valid CAS Registry Number.

176240-12-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-1-benzylpyrrolidine-2-carbaldehyde

1.2 Other means of identification

Product number -
Other names (S)-1-Benzyl-pyrrolidine-2-carbaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:176240-12-3 SDS

176240-12-3Relevant articles and documents

Expansion of substrate scope for nitroxyl radical/copper-catalyzed aerobic oxidation of primary alcohols: A guideline for catalyst selection

Iwabuchi, Yoshiharu,Nagasawa, Shota,Sasaki, Ryota,Sasano, Yusuke,Yamaichi, Aoto

, p. 488 - 497 (2021/05/27)

Four distinctive sets of optimum nitroxyl radical/copper salt/additive catalyst combinations have been identified for accommodating the aerobic oxidation of various types of primary alcohols to their corresponding aldehydes. Interestingly, less nucleophilic catalysts exhibited higher catalytic activities for the oxidation of particular primary allylic and propargylic alcohols to give α,β-unsaturated aldehydes that function as competent Michael acceptors. The optimum conditions identified herein were successful in the oxidation of various types of primary alcohols, including unprotected amino alcohols and divalent-sulfur-containing alcohols in good-to-high yields. Moreover, N-protected alaninol, an inefficient substrate in the nitroxyl radical/ copper-catalyzed aerobic oxidation, was oxidized in good yield. On the basis of the optimization results, a guideline for catalyst selection has been established.

Reduction of N,N-Dimethylcarboxamides to Aldehydes by Sodium Hydride–Iodide Composite

Chan, Guo Hao,Ong, Derek Yiren,Yen, Zhihao,Chiba, Shunsuke

, (2018/05/14)

A new and concise protocol for selective reduction of N,N-dimethylamides into aldehydes was established using sodium hydride (NaH) in the presence of sodium iodide (NaI) under mild reaction conditions. The present protocol with the NaH-NaI composite allows for reduction of not only aromatic and heteroaromatic but also aliphatic N,N-dimethylamides with wide substituent compatibility. Retention of α-chirality in the reduction of α-enantioriched amides was accomplished. Use of sodium deuteride (NaD) offers a new step-economical alternative to prepare deuterated aldehydes with high deuterium incorporation rate. The NaH-NaI composite exhibits unique chemoselectivity for reduction of N,N-dimethylamides over ketones.

Targeting Alzheimer's disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil

van Greunen, Divan G.,Cordier, Werner,Nell, Margo,van der Westhuyzen, Chris,Steenkamp, Vanessa,Panayides, Jenny-Lee,Riley, Darren L.

, p. 671 - 690 (2017/02/10)

A series of twenty seven acetylcholinesterase inhibitors, as potential agents for the treatment of Alzheimer's disease, were designed and synthesised based upon previously unexplored chemical space surrounding the molecular skeleton of the drug donepezil, which is currently used for the management of mild to severe Alzheimer's disease. Two series of analogues were prepared, the first looking at the replacement of the piperidine ring in donepezil with different sized saturated N-containing ring systems and the second looking at the introduction of different linkers between the indanone and piperidine rings in donepezil. The most active analogue 5,6-dimethoxy-1-oxo-2,3-dihydro-1H-inden-2-yl 1-benzylpiperidine-4-carboxylate (67) afforded an in vitro IC50value of 0.03 ± 0.07 μM against acetylcholinesterase with no cytotoxicity observed (IC50of >100 μM, SH-SY5Y cell line). In comparison donepezil had an IC50of 0.05 ± 0.06 μM and an observed cytotoxicity IC50of 15.54 ± 1.12 μM. Molecular modelling showed a strong correlation between activity and in silico binding in the active site of acetylcholinesterase.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 176240-12-3